Literature DB >> 11122246

Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.

A Fornasieri1, P Bernasconi, M L Ribero, R A Sinico, M Fasola, J Zhou, G Portera, A Tagger, A Gibelli, G D'amico.   

Abstract

The IgMk rheumatoid factors (RF) of type II mixed cryoglobulinaemia (MC) react, in 95% of cases, with MoAbs against the cross-reactive idiotypes (CRI) Cc1 or Lc1 (corresponding to the products of the VH1 and VH4 genes). MC is closely associated with HCV infection, a virus which infects lymphocytes and may replicate in B cells. It has been suggested that HCV may induce clonal selection of B cells producing monoclonal IgMk RF in type II MC. To verify whether HCV is enriched in B cells, and in the subsets expressing Cc1 and Lc1 CRI, we studied peripheral blood lymphocytes from eight patients with MC and HCV RNA-positive sera. Seven patients had RF reacting with anti-Cc1, the other with anti-Lc1 CRI. Total lymphocytes, T cells, B cells, and Cc1+ or Lc1+, Cc1- or Lc1- B cells were purified using MoAb-coated magnetic beads. Lymphocyte subsets were then diluted to give a range of 1 x 106-1 x 103 cells and tested for HCV RNA by reverse transcriptase-polymerase chain reaction. HCV was found exclusively in B cells in seven out of eight patients. In three patients HCV was enriched in the Cc1+ cells. In one of these patients, HCV was found exclusively in Cc1+ cells, with Cc1- cells being HCV-. The data indicate that B cells from type II MC patients are almost constantly infected by HCV. In selected cases, B cell subsets expressing IgMk RF CRI are the prevalent cell type infected by HCV. Our data suggest HCV involvement in B cell dysregulation leading to cryoprecipitable IgMk RF production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122246      PMCID: PMC1905803          DOI: 10.1046/j.1365-2249.2000.01396.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Hepatitis C virus in patients with cryoglobulinemia type II.

Authors:  M Pascual; L Perrin; E Giostra; J A Schifferli
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

Review 2.  Renal involvement in essential mixed cryoglobulinemia.

Authors:  G D'Amico; G Colasanti; F Ferrario; R A Sinico
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

3.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; P V Fosella; G Pasero; S Bombardieri
Journal:  Arthritis Rheum       Date:  1991-12

Review 4.  The diversity and idiotypic patterns of human rheumatoid factors in disease.

Authors:  S Fong; P P Chen; R I Fox; R D Goldfien; V Radoux; G J Silverman; J J Crowley; J Roudier; D A Carson
Journal:  Concepts Immunopathol       Date:  1988

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis.

Authors:  R A Sinico; C G Winearls; E Sabadini; A Fornasieri; A Castiglione; G D'Amico
Journal:  Kidney Int       Date:  1988-07       Impact factor: 10.612

7.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

8.  Infection of peripheral mononuclear blood cells by hepatitis C virus.

Authors:  A L Zignego; D Macchia; M Monti; V Thiers; M Mazzetti; M Foschi; E Maggi; S Romagnani; P Gentilini; C Bréchot
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

9.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

10.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

View more
  12 in total

1.  Complement C4 monitoring in the follow-up of chronic hepatitis C treatment.

Authors:  C Dumestre-Perard; D Ponard; C Drouet; V Leroy; J-P Zarski; N Dutertre; M G Colomb
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Authors:  E Zuckerman; G Slobodin; A Kessel; E Sabo; D Yeshurun; K Halas; E Toubi
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 3.  Hepatitis C virus-associated extrahepatic manifestations: a review.

Authors:  Damien Sène; Nicolas Limal; Patrice Cacoub
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 5.  Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors:  Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

6.  Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Authors:  Svetlana Marukian; Christopher T Jones; Linda Andrus; Matthew J Evans; Kimberly D Ritola; Edgar D Charles; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

Review 7.  Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors:  Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-12-07

8.  Solitary plasmacytoma of the jaw.

Authors:  Serena Marotta; Pierpaolo Di Micco
Journal:  J Blood Med       Date:  2010-03-30

Review 9.  Autoimmune manifestations in viral hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2012-07-28       Impact factor: 11.759

10.  The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.

Authors:  H Bumbea; A M Vladareanu; A Vintilescu; S Radesi; C Ciufu; M Onisai; C Baluta; M Begu; C Dobrea; V Arama; A Streinu-Cercel; S Arama
Journal:  J Med Life       Date:  2011-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.